Babson Diagnostics

Babson Diagnostics is a science-first healthcare technology company named 2024 Medtech Company of the Year by MD + DI, 2025 SXSW Innovation Award winner for Health & Biotech, and one of Fast Company’s 2025 Most Innovative Companies in Healthcare. Babson's mission is to make routine blood testing friendly, convenient, and affordable, empowering people to take charge of their health. Through rigorous, extensive clinical research, Babson has become the world's thought leader in the use of capillary blood for routine testing and developed technologies representing a new state of the art of diagnostics. In May 2024 Babson launched BetterWay™ blood testing—affordable fingertip collection at convenient locations with fast, accurate lab results in one to two days. BetterWay is available at over 20 Austin locations, including H-E-B, Sam’s Club, and clinics, and Babson is partnering with healthcare organizations across the U.S. to bring the BetterWay experience to their patients.